Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Study identifies potential therapeutic strategy for patients with clear cell renal cancer

Study identifies potential therapeutic strategy for patients with clear cell renal cancer

Breakthrough research could lead to a new wave of cancer-fighting antibodies

Breakthrough research could lead to a new wave of cancer-fighting antibodies

Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma

Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma

GW study examines impact of nervous system on non-alcoholic fatty liver disease

GW study examines impact of nervous system on non-alcoholic fatty liver disease

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Advances in radiation treatment help prolong, improve lives of people with anal cancer

Circadian clock could play key role in the fight against liver cancer

Circadian clock could play key role in the fight against liver cancer

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Study offers hope of early detection, treatment of liver cancer

Study offers hope of early detection, treatment of liver cancer

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

Study highlights accuracy of DecisionDx-Melanoma prognostic test in patients with Stage II-IIIA melanoma

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Head and neck cancer survivors more likely to commit suicide

Head and neck cancer survivors more likely to commit suicide

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

Patient-reported data confirms efficacy of brachytherapy alone in intermediate risk prostate cancer

Patient-reported data confirms efficacy of brachytherapy alone in intermediate risk prostate cancer

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.